Open AccessThe revolution of lung cancer treatment: from vaccines, to immune checkpoint inhibitors, to chimeric antigen receptor T therapy
Author(s) -
Yingcheng Wu,
Meng Jiang
Publication year - 2017
Publication title -
biotarget
Language(s) - English
Resource type - Journals
ISSN - 2522-669X
DOI - 10.21037/biotarget.2017.05.02
Subject(s) - chimeric antigen receptor , lung cancer , immunology , antigen , medicine , immune checkpoint , immune system , immunotherapy , cancer research , cancer , virology , oncology